199 related articles for article (PubMed ID: 31409896)
1. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
Shankaraiah RC; Callegari E; Guerriero P; Rimessi A; Pinton P; Gramantieri L; Silini EM; Sabbioni S; Negrini M
Oncogene; 2019 Nov; 38(45):7035-7045. PubMed ID: 31409896
[TBL] [Abstract][Full Text] [Related]
2. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
DePeralta DK; Wei L; Ghoshal S; Schmidt B; Lauwers GY; Lanuti M; Chung RT; Tanabe KK; Fuchs BC
Cancer; 2016 Apr; 122(8):1216-27. PubMed ID: 26914713
[TBL] [Abstract][Full Text] [Related]
3. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T; Pogribny IP; Rusyn I
Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.
Maeda M; Takami T; Terai S; Sakaida I
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():104-11. PubMed ID: 22320927
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.
Marrone AK; Shpyleva S; Chappell G; Tryndyak V; Uehara T; Tsuchiya M; Beland FA; Rusyn I; Pogribny IP
Mol Carcinog; 2016 May; 55(5):808-17. PubMed ID: 25865624
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
7. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
8. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
Chung SI; Moon H; Kim DY; Cho KJ; Ju HL; Kim DY; Ahn SH; Han KH; Ro SW
BMC Gastroenterol; 2016 Jan; 16():13. PubMed ID: 26821924
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
10. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
11. Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.
Xu A; Wang B; Fu J; Qin W; Yu T; Yang Z; Lu Q; Chen J; Chen Y; Wang H
Cancer Lett; 2019 Feb; 442():40-52. PubMed ID: 30401637
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.
Yasmin A; Regan DP; Schook LB; Gaba RC; Schachtschneider KM
Biochimie; 2021 Mar; 182():73-84. PubMed ID: 33444661
[TBL] [Abstract][Full Text] [Related]
14. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
15. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
Kluwe J; Wongsiriroj N; Troeger JS; Gwak GY; Dapito DH; Pradere JP; Jiang H; Siddiqi M; Piantedosi R; O'Byrne SM; Blaner WS; Schwabe RF
Gut; 2011 Sep; 60(9):1260-8. PubMed ID: 21278145
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
[TBL] [Abstract][Full Text] [Related]
17. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats.
Aziz TA; Aziz MA; Fouad HH; Rashed LA; Salama H; Abd-Alla S; Wehab MA; Ahmed T
Int J Mol Med; 2005 Jan; 15(1):21-6. PubMed ID: 15583823
[TBL] [Abstract][Full Text] [Related]
19. The DEN and CCl
Uehara T; Pogribny IP; Rusyn I
Curr Protoc; 2021 Aug; 1(8):e211. PubMed ID: 34370903
[TBL] [Abstract][Full Text] [Related]
20. Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c-H-ras proto-oncogene without mutations.
Tsunematsu S; Saito H; Kagawa T; Morizane T; Hata J; Nakamura T; Ishii H; Tsuchiya M; Nomura T; Katsuki M
Int J Cancer; 1994 Nov; 59(4):554-9. PubMed ID: 7960226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
